The treatment of Allergies & Senile Dementia with vitamins

Allergies and Senile Dementia: Mitamins custom make quality formulas for the treatment of Allergies & Senile Dementia with vitamins. A Allergies & Senile Dementia formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Allergies and Senile Dementia

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Vitamin E
    200
    IU
    667%
    Thiamin
    50
    mg
    3333%
    Vitamin B12
    125
    mcg
    2083%
    Lactobacillus acidolphilus
    100
    mg
    *
    Flax Seed Powder
    50
    mg
    *
    MSM
    100
    mg
    *
    Bioflavonoid Concentrate
    100
    mg
    *
  • Amount Per Serving
    % DV
    Ginkgo Extract
    40
    mg
    *
    Nettle Extract
    50
    mg
    *
    Quercetin
    100
    mg
    *
    Acetyl L-Carnitine
    250
    mg
    *
    Phosphatidylserine
    100
    mg
    *
    Betaine HCl
    50
    mg
    *
    Thymus
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Allergies and Senile Dementia
Serving Size:4-5

Allergies and Senile Dementia Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Artificial Cornea Saves Eyesight
Every year, in Germany alone, around 7000 people wait for a new cornea to save their eyesight. But donor corneas are in short supply. In an EU project, researchers have developed an artificial cornea which is to be clinically tested in early 2008.A patient whose cornea is damaged through a congenital malformation, hereditary disease or corrosion is at risk of going blind. One solution is to implant a donor cornea.
IPSOGEN In-Licenses NPM1 Mutations' Technology From XENOMICS
IPSOGEN, a leading molecular diagnostic company based in France and Connecticut, announced that it has signed a co-exclusive license agreement with XENOMICS (Pink Sheets: XNOM), a developer of next-generation medical DNA diagnostic technologies, based in USA. The license enables IPSOGEN to develop, manufacture and commercialize research and diagnostic products based on the analysis of NPM1 mutations for the stratification and monitoring of patients with Acute Myeloid Leukemia (AML).
This information concerning the support of Allergies and Senile Dementia treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments